GT
JNJ icon

Glenmede Trust’s Johnson & Johnson JNJ Stock Holding History

Glenmede Trust’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,000
Closed -$9.78M – 1536
2026
Q1 		$9.78M Buy
+40,000
New +$9.32M 0.05% 335
2022
Q3 		– Sell
-1,201
Closed -$3K – 1303
2022
Q2 		$3K Buy
+1,201
New +$214K ﹤0.01% 1274
2021
Q1 		– Sell
-542
Closed -$1K – 1229
2020
Q4 		$1K Buy
+542
New +$80K ﹤0.01% 1189

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Glenmede Trust's JNJ Position: Q2 2026 in Review

Glenmede Trust reduced its Johnson & Johnson (JNJ) stake by 7% in Q2 2026, selling an estimated $22.5M and leaving 1,286,261 shares worth $327M. The position accounts for 1.44% of the portfolio, ranked #12.

Glenmede Trust first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.24B in Q1 2018. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Glenmede Trust held 1,286,261 shares of Johnson & Johnson worth $327M as of Q2 2026.
  • Glenmede Trust sold 96,407 Johnson & Johnson shares in Q2 2026, an estimated $22.5M.
  • Johnson & Johnson made up 1.44% of Glenmede Trust's portfolio in Q2 2026, its #12 holding.
  • Glenmede Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's Johnson & Johnson position peaked at $1.24B in Q1 2018.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.